EMD Serono allies with ‘free sequencing’ firm Nebula

Free genomic sequencing in exchange for data use. EMD Serono, the US pharma division of Merck KGaA, has formed an alliance with Nebula Genomics, a startup that offers free genome sequencing – ... Lung cancer is of particular interest to EMD/Merck as it

Envision appoints new patient partnerships leader

Envision team recently won the ‘Best Practice’ A ward at ISMPP for its research on plain language summaries and a toolkit co-created with patients, industry, publishers and plain language specialists.

Type 1 diabetes prevention promise sends Provention Bio soaring

Teplizumab works by binding to the pro-inflammatory T cell co-receptor CD3, which in turn prevents them from activating the T cells that attack and kill the pancreas’ beta cells.

Merck & Co adds to immunotherapy again with $773m Tilos buy

Specialises in TGFβ complex-targeting therapies. Merck &Co is to acquire Tilos Therapeutics, a privately held biopharma specialising in novel immunotherapies, for up to $773m. ... The acquisition announced today shows that Merck (MSD outside North

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]